The global blood collection market size is estimated to be USD 5.92 billion in 2021 and is expected to witness a CAGR of 6.42% during the forecast period. Rise in demand for plasma due to growing cases of COVID 19 globally is a key driver for the growth of the global blood collection market. Additionally, increase in global number of accidents & trauma cases and occurrence of liquid biopsy tests are some of the other drivers propelling the market growth. Nevertheless, high price of automated blood collection devices and risks related with blood transfusions are expected to restrain the global market growth.
Based on product, the market is segmented into blood bags, needles and syringes, blood collection tubes, and others. In 2021, the needles and syringes segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increase in adoption of needles and syringes, recurring buying, and high affordability of needles worldwide. Blood bags segment projected to grow at a profitable CAGR during the forecast period. This is attributed to worldwide increase in the number of surgeries and accidents along with rise in number of blood transfusions and donations.
Based on application, the market is segmented into treatment and diagnostics. In 2021, the diagnostics segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increase in occurrence of chronic diseases such as diabetes, cancer, and cardiovascular diseases worldwide. Treatment segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing need for plasma due to growing cases of COVID 19 globally which requires prompt and precise treatment.
Based on end user, the market is categorized into blood banks, hospitals, diagnostics centers, and others. In 2021, the hospitals segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the fact that hospitals act as prime centers for treatment and diagnosis of diseases as the number of chronic diseases rising worldwide. The diagnostics centers is anticipated to grow at a profitable CAGR during the forecast period, due to the increasing accessibility of sophisticated equipment that allows in obtaining faster results.
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of major players in the region, increase in the share of healthcare expenditure in the per capita income, growth in initiatives from government for driving various blood donation camps, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the increase in disposable income, growing government and corporate investment in healthcare sector, rise in presence of major players in this region, are the major factors in this region. Competitor Insights Some of the key players in the blood collection market are Becton, Dickinson and Company (U.S.); Haematonics (U.S.); Terumo BCT (Japan); Fresenius Kabi AG (Germany); Grifols (Spain); Nipro Medical Corporation (Japan); Greiner Holding (Austria); Quest Diagnostics (U.S.); SARSTEDT AG & Co. (Germany); Macopharma (France); Smith’s Medical (U.S.); Kawasumi Laboratories (Japan); Retractable Technologies (U.S.); and LiuyangSanli Medical Technology Development (China). The leading players operating in the blood collection industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The blood collection market report is categorized into the following segments and subsegments:
By Product
Based on product, the market is segmented into blood bags, needles and syringes, blood collection tubes, and others. In 2021, the needles and syringes segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increase in adoption of needles and syringes, recurring buying, and high affordability of needles worldwide. Blood bags segment projected to grow at a profitable CAGR during the forecast period. This is attributed to worldwide increase in the number of surgeries and accidents along with rise in number of blood transfusions and donations.
By Application
Based on application, the market is segmented into treatment and diagnostics. In 2021, the diagnostics segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increase in occurrence of chronic diseases such as diabetes, cancer, and cardiovascular diseases worldwide. Treatment segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing need for plasma due to growing cases of COVID 19 globally which requires prompt and precise treatment.
By End User
Based on end user, the market is categorized into blood banks, hospitals, diagnostics centers, and others. In 2021, the hospitals segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the fact that hospitals act as prime centers for treatment and diagnosis of diseases as the number of chronic diseases rising worldwide. The diagnostics centers is anticipated to grow at a profitable CAGR during the forecast period, due to the increasing accessibility of sophisticated equipment that allows in obtaining faster results.
Regional Insights
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of major players in the region, increase in the share of healthcare expenditure in the per capita income, growth in initiatives from government for driving various blood donation camps, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the increase in disposable income, growing government and corporate investment in healthcare sector, rise in presence of major players in this region, are the major factors in this region. Competitor Insights Some of the key players in the blood collection market are Becton, Dickinson and Company (U.S.); Haematonics (U.S.); Terumo BCT (Japan); Fresenius Kabi AG (Germany); Grifols (Spain); Nipro Medical Corporation (Japan); Greiner Holding (Austria); Quest Diagnostics (U.S.); SARSTEDT AG & Co. (Germany); Macopharma (France); Smith’s Medical (U.S.); Kawasumi Laboratories (Japan); Retractable Technologies (U.S.); and LiuyangSanli Medical Technology Development (China). The leading players operating in the blood collection industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The blood collection market report is categorized into the following segments and subsegments:
Blood Collection Market, By Product (Revenue, USD Billion, 2021 - 2029)
- Blood Bags
- Needles and Syringes
Blood Collection Tubes
- Serum-separating
- EDTA
- Heparin
- Plasma-separating
- Others
Blood Collection Market, By Application (Revenue, USD Billion, 2021 - 2029)
- Treatment
- Diagnostics
Blood Collection Market, By End User (Revenue, USD Billion, 2021 - 2029)
- Blood banks
- Hospitals
- Diagnostics centers
- Others
Blood Collection Market, By Region (Revenue, USD Billion, 2021 - 2029)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Table of Contents
1. Research Methodology
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Blood Collection Market
7. Market Analysis by Product
8. Market Analysis by Application
9. Market Analysis by End User
10. Regional Market Analysis
11. North America Blood Collection Market
12. Europe Blood Collection Market
13. Asia Pacific Blood Collection Market
14. Latin America Blood Collection Market
15. MEA Blood Collection Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- Becton
- Dickinson and Company (U.S.)
- Haematonics (U.S.)
- Terumo BCT (Japan)
- Fresenius Kabi AG (Germany)
- Grifols (Spain)
- Nipro Medical Corporation (Japan)
- Greiner Holding (Austria)
- Quest Diagnostics (U.S.)
- SARSTEDT AG & Co. (Germany)
- Macopharma (France)
- Smith’s Medical (U.S.)
- Kawasumi Laboratories (Japan)
- Retractable Technologies (U.S.)
- LiuyangSanli Medical Technology Development (China)
